Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial - Wikidata - wikimedia - TriplyDB

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial

http://www.wikidata.org/entity/Q34598914

about

Interventions for female drug-using offenders Interventions for drug-using offenders with co-occurring mental illness Pharmacological interventions for drug-using offenders Opioid agonist maintenance for opioid dependent patients in prison Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence Interventions for female drug-using offenders Interventions for drug-using offenders with co-occurring mental illness Pharmacological interventions for drug-using offenders Opioid agonist maintenance for opioid dependent patients in prison Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions Mental health of prisoners: prevalence, adverse outcomes, and interventions Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry The effectiveness of opioid maintenance treatment in prison settings: a systematic review.Drug use and opioid substitution treatment for prisoners.HIV treatment in US prisons.Buprenorphine Treatment for Probationers and Parolees.An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners.Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.Medication-assisted treatment for opioid dependence: making a difference in prisons.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Linkage to care for HIV-infected heterosexual men in the United States Prevention of HIV infection among injection drug users in resource-limited settings.Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison: A Case Report.Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study.Medication-assisted treatment research with criminal justice populations: challenges of implementation.Buprenorphine-naloxone maintenance following release from jail.Public health and the epidemic of incarceration.

P2860

Q24187327-ECF41B9C-82D2-4EB8-B028-4D0725002A6E Q24187337-6D02A336-02A7-4B32-9E06-18F469D65EA0 Q24187352-A3E6C686-0D4B-42CC-B5CD-D0956704868F Q24188343-8760A093-3C43-4D78-A671-C4F823116692 Q24200539-3E9947F8-1530-4C5D-9EDA-6992635EB12F Q24201193-4B063D15-E637-4880-8EF8-A12BEB14F363 Q24201247-DA107581-86FD-44A7-B617-BDD99A4D45FB Q24201693-5736C6DF-93E8-484B-B528-04FF54099B59 Q24241630-49DAE964-0070-4F81-8639-5189F12D0F42 Q26746195-00DF7006-89E0-4C78-9649-3292E0C6AECC Q28078914-BED9D107-4484-4181-BC66-72B0CE9414DC Q28729018-9422825E-2CFD-4274-B441-79D50C0F0D5E Q30253083-CF32E25F-F97A-4834-B985-496859548AFF Q30277067-3DED136E-0378-4203-8A70-5C7D454D5458 Q30300924-85CAD6CE-5B3E-45BE-BCF3-98B1F117B690 Q30423352-06224D6F-0007-44F6-B86F-2757D5860CD1 Q33844064-C964F6AC-D9D2-49B2-B106-32669479F41D Q33898696-F907BA7B-FA74-4E59-BCEC-C3CD614BDC07 Q34030894-7541FB45-5E2D-4ECF-A8AB-1A5A93F3EC99 Q34033794-31285E83-D155-44E0-A8D6-B05008EB67CE Q34053733-B3235FBA-D205-4D49-B52B-F65FE71D9C6A Q34193216-A11F6233-A308-45DD-BB27-C89E7C254859 Q34289480-9510799D-DF5B-4286-A9A3-9381698C1CCF Q34315023-A3EDE7D2-A910-44F9-8B66-8C415FFA123C Q34425700-D82653A1-0697-4679-ADDC-E5741C8350F5 Q34472876-19352E8A-84C2-467D-BD74-CD0D78E66BC1 Q34478687-13CAB47F-C70D-455D-A825-4F39C8986C89 Q34589284-C673D2E9-12DA-4613-B7FE-6A46A4AF0017 Q34817072-3DDB27BC-A36A-40F1-87BA-83A8A8ED11D8 Q35019900-3A38686C-724A-459B-AC02-5781286360DD Q35043964-F14E38B9-408F-4780-9101-110C3C1F343F Q35088386-097E2FBE-393E-40F7-B8E4-33F2EE74E5BC Q35160035-7DB23ECF-3E20-46A6-B2CE-C8340D40DD4C Q35164557-89FF47C1-A309-4CFB-AA99-A24E1E7EBDDA Q35540686-BCDFE2D8-C78D-4F4D-8660-FCF3B04E4A6F Q35568702-B4F4CD68-2AB5-42B9-9890-5B94012715A7 Q35610989-5B5E4C53-EF09-46CC-9409-AFEE1AFF5D98 Q35627363-54E21D44-589E-473F-BA4B-1AB166923F73 Q35848205-B9EE023B-56C1-4D57-A994-715B36AD4D5E Q35898480-BDF76AB3-84F5-4BF3-AE94-45181A9F1C21

P2860

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial

http://www.wikidata.org/entity/Q34598914

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@ast

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@en

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@nl

type

label

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@ast

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@en

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@nl

prefLabel

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@ast

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@en

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@nl

P1433

Q34598914-B8951118-27C3-41FD-BC13-62CE90900139

P1476

Q34598914-85627FEF-E79C-4F1A-A7DA-5DD5B97CA41F

P2093

Q34598914-17A40912-D025-4545-9B03-10F3DEECD2FA

Q34598914-3424979D-910A-49F9-BCF1-F6838EE474F9

Q34598914-5C777EBE-91C1-4710-8A46-A20ECC12B9C9

Q34598914-88E1885F-0CA8-4A13-B2B4-C5254635EAFC

Q34598914-8C25D136-E3EF-441A-950A-9DCF0BFAB5DE

Q34598914-99E3C957-6E1C-4286-B952-C156AF6F2FF8

Q34598914-F07BB19D-AD28-416E-AE57-DA828E5828C2

P2860

Q34598914-0047BEB0-559A-4ED4-91BF-3F18C438C8A6

Q34598914-087D16E8-DD5C-4182-B603-0DF744EF7851

Q34598914-10BCB951-41C9-4A59-88B2-7AB86FA216DB

Q34598914-10F921D4-FD58-4CAD-9C85-3C6E06FDD45F

Q34598914-13ED5E58-A9F4-4C73-A90D-DCE02C1D510C

Q34598914-2B2626F2-7063-45E9-9638-BDAB3B288808

Q34598914-3B2EA784-25A0-474E-877B-03E0082C0C83

Q34598914-62791D93-7D50-49B9-9510-DDEA2A67BB28

Q34598914-7702D975-04F2-4B67-BD04-D5A8387DAC14

Q34598914-7763F593-4959-4B34-8070-D2CBB1F81D6C

P304

Q34598914-D3EA6281-A2FB-41C3-92FD-A4555652DF41

P31

Q34598914-A51F37FB-DC39-44D8-A60C-77A87F9C09DB

P356

Q34598914-1C91345E-FFB4-44FF-A2C0-E273257DD2EC

P433

Q34598914-60A4D159-9E2C-4278-8106-1091F0C6E131

P478

Q34598914-4CAA0DDF-B535-4983-979F-28F79A14C5CA

P577

Q34598914-E8203204-5A2E-4635-93DB-49DA63F36613

P5875

Q34598914-EA4A77C7-60C0-4284-8EE1-9574E2738BB5

P698

Q34598914-12A2A142-D155-4588-8326-32DCCF6927BC

P932

Q34598914-2E136262-D045-4B02-B0DA-F7E9ACB39984

P356

J.DRUGALCDEP.2008.08.006

P1433

Drug and Alcohol Dependence

P1476

Buprenorphine and methadone ma ...... e: a randomized clinical trial

@en

P2093

Andrew Rosenblum

http://www.w3.org/2001/XMLSchema#string

Carol Shropshire

http://www.w3.org/2001/XMLSchema#string

Herman Joseph

http://www.w3.org/2001/XMLSchema#string

Jason Hershberger

http://www.w3.org/2001/XMLSchema#string

Joshua D Lee

http://www.w3.org/2001/XMLSchema#string

Lisa Marsch

http://www.w3.org/2001/XMLSchema#string

Stephen Magura

http://www.w3.org/2001/XMLSchema#string

P2860

HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary.

Release from prison--a high risk of death for former inmates.

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Addiction, community and state: a review.

Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health

Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Buprenorphine: new pharmacological aspects.

Jail management of arrestees/inmates enrolled in community methadone maintenance programs.

A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release

The impact of substitution treatment in prisons--a literature review.

P304

222-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2008.08.006

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23394210

http://www.w3.org/2001/XMLSchema#string

P698

18930603

http://www.w3.org/2001/XMLSchema#string

P932

2658719

http://www.w3.org/2001/XMLSchema#string